Physical Address

304 North Cardinal St.
Dorchester Center, MA 02124

admin

admin

Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat ITP

Phase 3 data support rilzabrutinib as a potential first-in-class oral Bruton tyrosine kinase (BTK) inhibitor for patients with previously treated immune thrombocytopenia (ITP).  In the LUNA 3 trial, treatment with rilzabrutinib (Sanofi) led to rapid and durable platelet responses, reduced…

Up to 30% of Patients in German Hospitals Are Malnourished

Between 20% and 30% of hospitalized patients in Germany suffer from malnutrition, which may result in serious consequences in some cases. “Malnutrition is not a minor issue. It often leads to complications during treatment and significantly reduces the quality of…

Push for synbio tech to be widely applied

Local manufacturers must step up efforts to seriously adopt synbio technology to develop new value-added products in order to better compete with rivals, including those that are adept at producing low-cost products, says the Federation of Thai Industries (FTI). Synbio,…

en_USEnglish